Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Australian Prescriber
|
August 27, 2025
Practical guidance for stopping glucocorticoids
Faran Khalili, Morton G Burt
European Journal of Endocrinology
|
October 10, 2018
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Anjana Radhakutty, Morton G Burt
Internal Medicine Journal
|
November 7, 2017
Optimising pituitary surgery outcomes in Australia: how much does size matter?
Ann I McCormack, Morton G Burt
Clinical Endocrinology
|
November 11, 2022
Cardio-metabolic pathophysiology in mild glucocorticoid excess: Potential implications for management of adrenal incidentaloma
Angela X Chen, Morton G Burt
Australian Prescriber
|
January 30, 2018
Hyperprolactinaemia
Angela X Chen, Morton G Burt
Endocrinology, Diabetes & Metabolism Case Reports
|
December 23, 2025
A potentially dangerous case of mistaken identity: giant asymptomatic composite phaeochromocytoma
Annabelle G Hayes, Morton G Burt
Endocrine
|
May 2, 2003
Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly
Morton G Burt, Ken K Y Ho
The New Zealand Medical Journal
|
April 9, 2002
False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia
Morton G Burt, Berry Allen, John V Conaglen
Clinical Endocrinology
|
October 12, 2013
Factitious Cushing's syndrome masquerading as Cushing's disease
Tilenka Thynne, Graham H White, Morton G Burt
American Journal of Physiology. Endocrinology and Metabolism
|
January 25, 2007
Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment
Morton G Burt, James Gibney, Ken K Y Ho
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Australian Prescriber
|
August 27, 2025
Practical guidance for stopping glucocorticoids
Faran Khalili, Morton G Burt
European Journal of Endocrinology
|
October 10, 2018
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Anjana Radhakutty, Morton G Burt
Internal Medicine Journal
|
November 7, 2017
Optimising pituitary surgery outcomes in Australia: how much does size matter?
Ann I McCormack, Morton G Burt
Clinical Endocrinology
|
November 11, 2022
Cardio-metabolic pathophysiology in mild glucocorticoid excess: Potential implications for management of adrenal incidentaloma
Angela X Chen, Morton G Burt
Australian Prescriber
|
January 30, 2018
Hyperprolactinaemia
Angela X Chen, Morton G Burt
Endocrinology, Diabetes & Metabolism Case Reports
|
December 23, 2025
A potentially dangerous case of mistaken identity: giant asymptomatic composite phaeochromocytoma
Annabelle G Hayes, Morton G Burt
Endocrine
|
May 2, 2003
Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly
Morton G Burt, Ken K Y Ho
The New Zealand Medical Journal
|
April 9, 2002
False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia
Morton G Burt, Berry Allen, John V Conaglen
Clinical Endocrinology
|
October 12, 2013
Factitious Cushing's syndrome masquerading as Cushing's disease
Tilenka Thynne, Graham H White, Morton G Burt
American Journal of Physiology. Endocrinology and Metabolism
|
January 25, 2007
Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment
Morton G Burt, James Gibney, Ken K Y Ho
Page
of 7